Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure

Tablo 4 incelendiğinde deney ve kontrol grubunun Toplumsal Cinsiyet Algısı Ölçeği sontest puanları arasında anlamlı bir farklılık olup olmadığını belirlemek için

The Worcester Heart Failure study including 9,748 ADHF pa- tients found higher in-hospital and post-discharge (1 and 2 years after discharge) mortality rates in patients

(1) recently published in the Anatol J Cardiol 2017; 18: 206-12 and the edito- rial comment entitled 'Tolvaptan in the very elderly with acute decompensated heart failure-

(1) recently published in the Anatol J Cardiol 2017; 18: 206-12 and the edito- rial comment entitled 'Tolvaptan in the very elderly with acute decompensated heart failure-

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.. Felker GM, Mentz RJ,

BNP - plasma brain natriuretic peptide; CHF - chronic heart failure; CHFC - CHF control group; CHFT - CHF testing group; hsCRP - plasma high sensitive C-reactive protein; IL-1β

CV - cardiovascular; DD - diastolic dysfunction; EF - ejection fraction; HFpEF - heart failure with preserved ejection fraction; HFrEF - heart failure with reduced ejection

The ability of albumin to bind to cobalt is reduced in patients with myocardial ischemia, providing the basis for the albumin cobalt-binding test for detecting IMA (5).. IMA is